Finally, the complex interplay of KLF9 with its related family members in breast cancer, and epithelial cancer biology in general, still remains largely elusive and needs to be thoroughly investigated in order to identify downstream genes as potential therapeutic targets or mediators of metastatic progression. This evidence concerns the gene KLF9 and breast carcinoma.